Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects

被引:52
作者
Hettinga, Johanna [1 ]
Carlisle, Robert [1 ]
机构
[1] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford OX3 7DQ, England
基金
英国生物技术与生命科学研究理事会; 英国工程与自然科学研究理事会;
关键词
vaccine; transcutaneous; intradermal; microneedles; ballistic delivery; DNA tattooing; skin permeabilization; electroporation; INACTIVATED POLIOVIRUS VACCINE; INTRADERMAL INFLUENZA VACCINE; T-CELL RESPONSES; EFFECTIVE TRANSCUTANEOUS IMMUNIZATION; ULTRASOUND-MEDIATED CAVITATION; HIGH-FREQUENCY ULTRASOUND; PHASE-1; CLINICAL-TRIAL; DNA VACCINE; GENE-GUN; DRUG-DELIVERY;
D O I
10.3390/vaccines8030534
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In 2019, an 'influenza pandemic' and 'vaccine hesitancy' were listed as two of the top 10 challenges to global health by the WHO. The skin is a unique vaccination site, due to its immune-rich milieu, which is evolutionarily primed to respond to challenge, and its ability to induce both humoral and cellular immunity. Vaccination into this dermal compartment offers a way of addressing both of the challenges presented by the WHO, as well as opening up avenues for novel vaccine formulation and dose-sparing strategies to enter the clinic. This review will provide an overview of the diverse range of vaccination techniques available to target the dermal compartment, as well as their current state, challenges, and prospects, and touch upon the formulations that have been developed to maximally benefit from these new techniques. These include needle and syringe techniques, microneedles, DNA tattooing, jet and ballistic delivery, and skin permeabilization techniques, including thermal ablation, chemical enhancers, ablation, electroporation, iontophoresis, and sonophoresis.
引用
收藏
页码:1 / 40
页数:40
相关论文
共 279 条
  • [1] Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost
    Ake, Julie A.
    Schuetz, Alexandra
    Pegu, Poonam
    Wieczorek, Lindsay
    Eller, Michael A.
    Kibuuka, Hannah
    Sawe, Fredrick
    Maboko, Leonard
    Polonis, Victoria
    Karasavva, Nicos
    Weiner, David
    Sekiziyivu, Arthur
    Kosgei, Josphat
    Missanga, Marco
    Kroidl, Arne
    Mann, Philipp
    Ratto-Kim, Silvia
    Eller, Leigh Anne
    Earl, Patricia
    Moss, Bernard
    Dorsey-Spitz, Julie
    Milazzo, Mark
    Ouedraogo, G. Laissa
    Rizvi, Farrukh
    Yan, Jian
    Khan, Amir S.
    Peel, Sheila
    Sardesai, Niranjan Y.
    Michael, Nelson L.
    Ngauy, Viseth
    Marovich, Mary
    Robb, Merlin L.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (09) : 1080 - 1090
  • [2] Dermal exposure to aqueous solutions of N-methyl pyrrolidone
    Akrill, P
    Cocker, J
    Dixon, S
    [J]. TOXICOLOGY LETTERS, 2002, 134 (1-3) : 265 - 269
  • [3] Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule
    Anand, Abhijeet
    Molodecky, Natalie A.
    Pallansch, Mark A.
    Sutter, Roland W.
    [J]. VACCINE, 2017, 35 (22) : 2993 - 2998
  • [4] Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial
    Anand, Abhijeet
    Zaman, K.
    Estivariz, Concepcion F.
    Yunus, Mohammad
    Gary, Howard E.
    Weldon, William C.
    Bari, Tajul I.
    Oberste, M. Steven
    Wassilak, Steven G.
    Luby, Stephen P.
    Heffelfinger, James D.
    Pallansch, Mark A.
    [J]. VACCINE, 2015, 33 (48) : 6816 - 6822
  • [5] Optimization of microdermabrasion for controlled removal of stratum corneum
    Andrews, Samantha N.
    Zarnitsyn, Vladimir
    Bondy, Brian
    Prausnitz, Mark R.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 407 (1-2) : 95 - 104
  • [6] [Anonymous], 2012, INT J PHARM PHARM SC
  • [7] [Anonymous], 2020, DRAFT LANDSCAPE COVI
  • [8] Ansaldi F, 2012, EXPERT REV VACCINES, V11, P17, DOI [10.1586/ERV.11.154, 10.1586/erv.11.154]
  • [9] Bacterial spores as particulate carriers for gene gun delivery of plasmid DNA
    Aps, Luana R. M. M.
    Tavares, Milene B.
    Rozenfeld, Julio H. K.
    Lamy, M. Teresa
    Ferreira, Luis C. S.
    Diniz, Mariana O.
    [J]. JOURNAL OF BIOTECHNOLOGY, 2016, 228 : 58 - 66
  • [10] Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A randomized controlled phase III study
    Arakane, Ryo
    Annaka, Ryosuke
    Takahama, Akiko
    Ishida, Katsuyasu
    Yoshiike, Michiharu
    Nakayama, Tetsuo
    Takeshita, Fumihiko
    [J]. VACCINE, 2015, 33 (48) : 6650 - 6658